Kolltan Pharmaceuticals Inc. and The Children's Hospital of Philadelphia to Initiate Collaboration in Pediatric Neuroblastoma
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NEW HAVEN, Conn.--(BUSINESS WIRE)--Kolltan Pharmaceuticals, Inc., a privately held biopharmaceutical company, today announced a license and research agreement with The Children’s Hospital of Philadelphia (CHOP) to commence a collaboration with Yaël Mossé, M.D, an internationally recognized clinician and scientist for her work studying the causes and novel therapeutic approaches for the treatment of children diagnosed with neuroblastoma.
Help employers find you! Check out all the jobs and post your resume.
NEW HAVEN, Conn.--(BUSINESS WIRE)--Kolltan Pharmaceuticals, Inc., a privately held biopharmaceutical company, today announced a license and research agreement with The Children’s Hospital of Philadelphia (CHOP) to commence a collaboration with Yaël Mossé, M.D, an internationally recognized clinician and scientist for her work studying the causes and novel therapeutic approaches for the treatment of children diagnosed with neuroblastoma.
Help employers find you! Check out all the jobs and post your resume.